ArticleEcancermedicalscience2025

A pilot study on the neurocognitive effect of sorafenib on patients with desmoid tumours: the SORA-COG study.

Kamboji Sharanya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.